Silencing of Ac45 Simultaneously Inhibits Osteoclast-Mediated Bone Resorption and Attenuates Dendritic Cell-Mediated Inflammation through Impairing Acidification and Cathepsin K Secretion

Infect Immun. 2020 Dec 15;89(1):e00436-20. doi: 10.1128/IAI.00436-20. Print 2020 Dec 15.

Abstract

Endodontic disease is characterized by inflammation and destruction of periapical tissues, leading to severe bone resorption and tooth loss. ATP6AP1 (Ac45) has been implicated in human immune diseases, yet the mechanism underlying how Ac45 regulates immune response and reaction in inflammatory diseases remains unknown. We generated endodontic disease mice through bacterial infection as an inflammatory disease model and used adeno-associated virus (AAV)-mediated Ac45 RNA interference knockdown to study the function of Ac45 in periapical inflammation and bone resorption. We demonstrated that the AAV small hairpin RNA targeting Ac45 (AAV-sh-Ac45) impaired cellular acidification, extracellular acidification, and bone resorption. Our results showed that local delivery of AAV-sh-Ac45 in periapical tissues in bacterium-induced inflammatory lesions largely reduced bone destruction, inhibited inflammation, and dramatically reduced mononuclear immune cells. T-cell, macrophage, and dendritic cell infiltration in the periapical lesion was dramatically reduced, and the periodontal ligament was protected from inflammation-induced destruction. Furthermore, AAV-sh-Ac45 significantly reduced osteoclast formation and the expression of proinflammatory cytokines, such as tumor necrosis factor alpha, interleukin-10 (IL-10), IL-12, IL-1α, IL-6, and IL-17. Interestingly, AAV-sh-Ac45 impaired mature cathepsin K secretion more significantly than that by AAV-sh-C1 and AAV-sh-CtsK Unbiased genome-wide transcriptome sequencing analysis of Ctsk-/- dendritic cells stimulated with lipopolysaccharide demonstrated that the ablation of Ctsk dramatically reduced dendritic cell-mediated inflammatory signaling. Taken together, our results indicated that AAV-sh-Ac45 simultaneously inhibits osteoclast-mediated bone resorption and attenuates dendritic cell-mediated inflammation through impairing acidification and cathepsin K secretion. Thus, Ac45 may be a novel target for therapeutic approaches to attenuate inflammation and bone erosion in endodontic disease and other inflammation-related osteolytic diseases.

Keywords: Ac45; RNAi silencing; adeno-associated virus; bone resorption; endodontic disease; inflammation.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Alveolar Bone Loss / etiology
  • Alveolar Bone Loss / metabolism
  • Alveolar Bone Loss / pathology
  • Animals
  • Bone Resorption / genetics*
  • Bone Resorption / metabolism
  • Bone Resorption / pathology
  • Cathepsin K / biosynthesis*
  • Cell Count
  • Cytokines / genetics
  • Cytokines / metabolism
  • Dendritic Cells / immunology
  • Dendritic Cells / metabolism*
  • Dependovirus / genetics
  • Disease Models, Animal
  • Gene Knockdown Techniques
  • Gene Silencing*
  • Hydrogen-Ion Concentration
  • Inflammation / etiology
  • Inflammation / metabolism
  • Inflammation / pathology
  • Mice
  • Osteoclasts / metabolism*
  • RNA Interference
  • T-Lymphocytes / immunology
  • T-Lymphocytes / metabolism
  • Transduction, Genetic
  • Vacuolar Proton-Translocating ATPases / genetics*

Substances

  • Atp6ap1 protein, mouse
  • Cytokines
  • Cathepsin K
  • Vacuolar Proton-Translocating ATPases